Latest filing published 20 Feb 2013 for Abbott Laboratories.
Insider track record
No signal scores available.
Paul K. Magill: trading record in brief
All filings by Paul K. Magill on record concern Abbott Laboratories. We count 2 filings; the first trade dates from 1 November 2012 and the latest from 15 February 2013.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 20 February 2013: a share grant, in Abbott Laboratories. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Paul K. Magill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 23,000 shares0Common shares without par valueSEC:0001179110-13-003143:0
- 10,000 shares0Common shares without par valueSEC:0001179110-12-015694:0
2 of 2 declarations
